WallStreetZenWallStreetZen

NASDAQ: ATHE
Alterity Therapeutics Ltd Stock Ownership - Who owns Alterity Therapeutics?

Insider buying vs selling

Have Alterity Therapeutics Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ATHE insiders and whales buy or sell their stock.

ATHE Shareholders

What type of owners hold Alterity Therapeutics Ltd stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Morgan Stanley0.00%51,485$135.41kInstitution
Twin Lakes Capital Management LLC0.00%5,925$15.58kInstitution
Providence Capital Advisors LLC0.00%200$526.00Institution
Coppell Advisory Solutions LLC0.00%149$391.87Institution
Ubs Group Ag0.00%127$334.01Institution
Osaic Holdings Inc0.00%81$213.03Institution
Sugarloaf Wealth Management LLC0.00%33$86.79Institution
Steward Partners Investment Advisory LLC0.00%6$15.78Institution
Concourse Financial Group Securities Inc0.00%0$0.00Institution

1 of 1

ATHE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ATHE0.00%0.00%
MAIA2.24%26.77%Net Buying
AGE12.71%87.29%Net Selling
PHGE16.27%34.63%Net BuyingNet Selling
OGEN0.15%99.85%Net SellingNet Selling

Alterity Therapeutics Stock Ownership FAQ

Who owns Alterity Therapeutics?

Alterity Therapeutics (NASDAQ: ATHE) is owned by 0.00% institutional shareholders, 0.00% Alterity Therapeutics insiders, and 100.00% retail investors. Morgan Stanley is the largest individual Alterity Therapeutics shareholder, owning 51,485.00 shares representing 0.00% of the company. Morgan Stanley's Alterity Therapeutics shares are currently valued at $135.41k.

If you're new to stock investing, here's how to buy Alterity Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.